Anette Klinger
Impact in
- Toxicology top 10%
- Bioactive Compounds and Antitumor Agents
-
- Drug Transport and Resistance Mechanisms
Papers in
-
- Cancer therapeutics and mechanisms 4
- Histone Deacetylase Inhibitors Research 4
- Protein Degradation and Inhibitors 2
- Oncology 9
- Drug Transport and Resistance Mechanisms 4
- Cancer Treatment and Pharmacology 2
- Co-authors
- Edmond Fleischer (18 shared papers)Thomas Efferth (15 shared papers)Sara Abdelfatah (5 shared papers)Mikhail V. Keniya (2 shared papers)Brian C. Monk (2 shared papers)Richard D. Cannon (1 shared paper)Mona Dawood (5 shared papers)Sami Hamdoun (2 shared papers)
In The Last Decade
Anette Klinger
20 papers receiving 357 citations
Peers
Comparison fields: 5 of 70
- Toxicology 21
- Oncology 102
- Molecular Biology 217
- Infectious Diseases 56
- Computational Theory and Mathematics 41
Countries citing papers authored by Anette Klinger
This map shows the geographic impact of Anette Klinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anette Klinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anette Klinger more than expected).
Fields of papers citing papers by Anette Klinger
This network shows the impact of papers produced by Anette Klinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anette Klinger. The network helps show where Anette Klinger may publish in the future.
Co-authors
The 25 scholars most cited alongside Anette Klinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 51 | |
| 2 | 2013 | 49 | |
| 3 | 2020 | 42 | |
| 4 | 2019 | 30 | |
| 5 | 2017 | 25 | |
| 6 | 2020 | 19 | |
| 7 | 2019 | 18 | |
| 8 | 2020 | 14 | |
| 9 | 2022 | 14 | |
| 10 | 2021 | 13 | |
| 11 | 2020 | 13 | |
| 12 | 2019 | 13 | |
| 13 | 1998 | 13 | |
| 14 | 2019 | 10 | |
| 15 | 2020 | 9 | |
| 16 | 2024 | 7 | |
| 17 | 2021 | 7 | |
| 18 | 2020 | 7 | |
| 19 | 2021 | 5 | |
| 20 | 2020 | 3 |
About Anette Klinger
Anette Klinger is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Pharmacology and Hematology, having authored 20 papers that have together received 362 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (4 papers), Histone Deacetylase Inhibitors Research (4 papers), Drug Transport and Resistance Mechanisms (4 papers), Microtubule and mitosis dynamics (3 papers), Cancer Treatment and Pharmacology (2 papers), Protein Degradation and Inhibitors (2 papers), Microbial Natural Products and Biosynthesis (2 papers) and Cancer, Stress, Anesthesia, and Immune Response (2 papers). The work is most often cited by research in Toxicology (21 citations), Oncology (102 citations), Molecular Biology (217 citations), Infectious Diseases (56 citations) and Computational Theory and Mathematics (41 citations). Anette Klinger has collaborated with scholars based in Germany, Sudan and China. Frequent co-authors include Edmond Fleischer, Thomas Efferth, Sara Abdelfatah, Mikhail V. Keniya, Brian C. Monk, Richard D. Cannon, Mona Dawood, Sami Hamdoun, Jörg Schröder and Frank Oellien. Their work appears in journals such as Investigational New Drugs, Biochemical Pharmacology, Phytomedicine, Pharmacological Research and Acta Pharmaceutica Sinica B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.